CHARM Therapeutics
Boston, United States· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $80M
Overview
An AI-driven company using 3D deep learning to design small molecule drugs for cancer.
Oncology
Technology Platform
DragonFold, a 3D deep learning platform that predicts protein-ligand structures to design small molecules for difficult-to-drug targets.
Funding History
1Total raised:$80M
Venture$80M
Opportunities
Potential to rapidly generate drug candidates for high-value, previously undruggable oncology targets.
Risk Factors
Risk that its AI-predicted structures and molecule designs may not translate into effective and druggable compounds in vivo.
Competitive Landscape
Competes with other AI-drug discovery firms, but with a specialized focus on 3D structure prediction for oncology.